跳至主要内容
临床试验/TCTR20240804001
TCTR20240804001招募中3 期

Child Life Services in Pediatric Stem Cell Transplantation

Faculty of Medicine Ramathibodi Hospital, Mahidol University0 个研究点目标入组 20 人开始时间: 2024年8月4日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Years 至 8 Years(—)
性别
All

入选标准

  • 1. Children aged 2-8 who have received bone marrow transplants at Ramathibodi Hospital.
  • 2. Parents who can read, listen, and write in the Thai language.
  • 3. Parents and child patients who consent to participate in the research project.

排除标准

  • 1. Parents and child patients who did not complete the questionnaire.
  • 2. Parents and child patients who refuse to participate in the research project.

研究者

相似试验

进行中(未招募)
1 期
Allogeneic stem cell transplantation for children and adolescents with CML: Conditioning regimen, donor selection, supportive care and diagnostic procedures - CML SCT I-BFMChronic Myeloid LeukemiaMedDRA version: 12.1Level: LLTClassification code 10009700Term: CM
EUCTR2008-000569-50-ITSt. Anna Kinderkrebsforschung160
进行中(未招募)
1 期
Allogeneic stem cell transplantation for children, adolescents and young adults with acute myeloid leukemia
EUCTR2007-004517-34-CZHannover Clinical Trial Center GmbH153
进行中(未招募)
1 期
Stem cell transplantation for young people with severe blood cancerRelapsed or refractory Acute Myeloid Leukemia (AML)MedDRA version: 20.0 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10067859 Term: Allogenic stem cell transplantation System Organ Class: 100000004865
EUCTR2007-004517-34-DEHannover Medical School153
进行中(未招募)
1 期
Allogeneic stem cell transplantation for children, adolescents and young adults with relapsed or refractory AML - AML SCT-BFM 2007To evaluate whether stem cell transplantation from a matched sibling donor is equivalent to a matched unrelated donor in a second complete remissionto evaluate whether stem cell transplantation after FLAMSA increases survival compared to a threshold derived from historical data (1-year Survival 10%)to evaluate whether stem cell transplantation from haploidentical donors for children having no matched donor will result in better survival with acceptable toxicity.
EUCTR2007-004517-34-ATHannover Clinical Trial Center GmbH136
招募中
3 期
ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia
2024-512657-24-00St. Anna Childrens Cancer Research Institute GmbH1,108